Laboratory of Biology of Tumor and Development

The main topics of our lab include cancer and tumor microenvironment, with a focus on (lymph)angiogenesis, matrix remodeling, and metastatic dissemination.

Research

Lymphangiogenesis and microenvironment

Agnès Noël

Extracellular matrix interactions in cancer

Erik Maquoi

Fertility preservation and endometriosis

Carine Munaut

Estrogen-sensitive tissues and cancer

Christel Pequeux

Resistance and vulnerabilities in lung cancer

Marie-Julie Nokin

Cancer metabolism and tumor microenvironment

Nor Eddine Sounni

News

01
02
03

01

03

A new combination therapy to inhibit the growth of 50% of triple-negative breast cancers

This work of Dr. Nor Eddine Sounni's team (GIGA-Cancer) has just been published in Clinical Cancer Research.

Learn more

Discovery of a molecule that can regulate the formation of lymphatic vessels

This important advance for the treatment of cancers discovered by the team of Pr. Agnès Noël (GIGA-Cancer) has just been published in the prestigious journal Nature Communications.

Learn more

Immunity and cancer : new breakthroughs through epigenetics

Researchers from ULB and ULiège (GIGA-Cancer) are making progress in understanding the interaction between immune cells and cancer cells, via the deregulation of the epigenetic machinery. Their study is published in the journal Science Advances.

Learn more

Find a researcher

Access our directory

Contact

Laboratory of Biology of Tumor and Development

GIGA
Université de Liège
Avenue Hippocrate, 13
Tour de Pathologie, B23/+4
Sart-Tilman, B-4000 Liège
BELGIUM

On social networks

11 Feb 2026

Learn more

11 Feb 2026

Journée Internationale de femmes et filles de science : Stéphanie Herkenne apporte son regard sur les obstacles rencontrés et les évolutions observées.

Learn more

26 Jan 2026

🧬 Nouveaux équipements à la plateforme génomique La plateforme GIGA Genomics renforce ses capacités avec l’acquisition de trois séquenceurs de dernière génération : AVITI (Element Biosciences), ...

Learn more

Our partners